16 results
8-K
RAPH
Raphael Pharmaceutical Inc.
2 May 24
Other Events
4:04pm
, the Company’s technology may not be validated as it progresses further and its methods may not be accepted by the scientific community; the Company may
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:56am
by physicians, patients, third-party payors and others in the medical community.
Even with the requisite approvals from the FDA and comparable foreign … regulatory authorities, the commercial success of our product candidates will depend in part on the medical community, patients and third-party payors
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:55am
the degree of market acceptance by physicians, patients, third-party payors and others in the medical community.
Even with the requisite approvals from … the FDA and comparable foreign regulatory authorities, the commercial success of our product candidates will depend in part on the medical community
POS AM
RAPH
Raphael Pharmaceutical Inc.
4 May 23
Prospectus update (post-effective amendment)
4:01pm
upon the degree of market acceptance by physicians, patients, third-party payors and others in the medical community.
Even with the requisite approvals … community, patients and third-party payors accepting our product candidates as medically useful, cost-effective and safe. Any product that we bring
POS AM
02of 3q9qgklb
2 May 23
Prospectus update (post-effective amendment)
4:02pm
POS AM
22oe7sucii 6evvm
26 May 22
Prospectus update (post-effective amendment)
9:28am
10-12G/A
sx4gie p556n
23 Sep 21
Registration of securities (amended)
6:19am
10-12G/A
2gi4hx
2 Sep 21
Registration of securities (amended)
5:28pm
10-12G
saj2tm08rzoxpog 6y8
29 Jul 21
Registration of securities
12:00am
10-12G/A
amx1gu7vmcg4
2 Jul 21
Registration of securities (amended)
4:15pm
10-12G
t7ib63fv5i0cuzu
14 May 21
Registration of securities
5:27pm
- Prev
- 1
- Next